Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04011696
Other study ID # 264296
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 3, 2019
Est. completion date May 31, 2022

Study information

Verified date November 2023
Source Brighton and Sussex University Hospitals NHS Trust
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators are proposing this research project to: 1. Screen a set of patients after normal cataract surgery with a single focus lens aimed at good distance vision at 3 months after surgery to identify patients who are able to see and read well without glasses. 2. Identify the combination of factors responsible for this phenomenon in the patients who are achieving this. Potentially eligible patients will be given an invitation letter and patient information sheet on the day they arrive for surgery. They will then be asked if they are happy to be contacted by phone 2-4 weeks post-surgery with a view to booking them into an additional research visit at 3 months after their surgery. At 3 months after surgery they will have their un-corrected vision checked. They will also have their reading speed assessed without any glasses. They will undergo a through refractive check by an optometrist to assess the power of the spectacles (if needed) and following this they will have a scan of the eye (a technique known as wave front analysis which uses very sophisticated optics) to capture the optical distortions in the structures of the eye. If this study is able identify factor/s responsible for giving good unaided reading and distance vision then this factor can be reproduced in eyes undergoing cataract surgery. This will mean that the patients can have an increased option of spectacle independence without the need for expensive multifocal IOLs and their associated side effects such as glare and halos, particularly at night.


Description:

TYPE OF THE STUDY: A prospective, non-blinded, non-randomized, single eye cohort study in patients who had uneventful cataract surgery with a monofocal IOL. Potentially eligible patients will be given an invitation letter and patient information sheet on the day they arrive for surgery. They will then be asked if they are happy to be contacted by phone 2-4 weeks post-surgery with a view to booking them into an additional research visit at 3 months after their surgery. Inclusion criteria 1. Uneventful cataract surgery 2. Sequential recruitment 3. Potential to see 20/40 (6/12) unaided or better postoperatively 4. No significant macular pathology 5. Willing to follow up at 3 months Exclusion criteria 1. Patients under 20 years of age 2. Any ocular co-morbidity, which will preclude an expected postoperative 20/40 (6/12) unaided, distance vision. (e.g. amblyopia, corneal pathology, age related macular degeneration, glaucoma, diabetic retinopathy, other previous ocular surgeries) 3. Posterior capsule opacification 4. Inability to read English text or physically or mentally unable to cooperate with the postoperative assessment At 3 months, uniocular unaided distance LogMAR acuity will be recorded. An OCT scan will be performed to establish macular integrity. Pupil size, manifest refraction, measurement of any deviations of the optical rays (called as wavefront aberrometry) will be performed using a iTrace (Tracy Technology) wavefront aberrometer. Unaided reading speed and critical print size will be measured using a Salzberg Reading Desk. Examination time per patient: 40 mins in total. Multivariate statistical analysis will be performed. Power calculation showed a need to examine 412 patients.


Recruitment information / eligibility

Status Completed
Enrollment 412
Est. completion date May 31, 2022
Est. primary completion date May 31, 2022
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Uneventful cataract surgery, sequential recruitment, potential to see 20/40 (6/12) unaided or better postoperatively, no significant macular pathology and willing to follow up at 3 months. Exclusion Criteria: - Any ocular co-morbidity, which will preclude an expected postoperative 20/40 (6/12) unaided, distance vision. (e.g. amblyopia, corneal pathology, age related macular degeneration, glaucoma, diabetic retinopathy, other previous ocular surgeries), posterior capsule opacification,inability to read English text or physically or mentally unable to and cooperate with the postoperative assessment

Study Design


Locations

Country Name City State
United Kingdom Mayank Nanavaty Brighton

Sponsors (3)

Lead Sponsor Collaborator
Brighton and Sussex University Hospitals NHS Trust European Society of Cataract and Refractive Surgeons, King's College London

Country where clinical trial is conducted

United Kingdom, 

References & Publications (3)

Nanavaty MA, Spalton DJ, Boyce J, Saha S, Marshall J. Wavefront aberrations, depth of focus, and contrast sensitivity with aspheric and spherical intraocular lenses: fellow-eye study. J Cataract Refract Surg. 2009 Apr;35(4):663-71. doi: 10.1016/j.jcrs.2008.12.011. — View Citation

Nanavaty MA, Spalton DJ, Marshall J. Effect of intraocular lens asphericity on vertical coma aberration. J Cataract Refract Surg. 2010 Feb;36(2):215-21. doi: 10.1016/j.jcrs.2009.08.024. — View Citation

Nanavaty MA, Vasavada AR, Patel AS, Raj SM, Desai TH. Analysis of patients with good uncorrected distance and near vision after monofocal intraocular lens implantation. J Cataract Refract Surg. 2006 Jul;32(7):1091-7. doi: 10.1016/j.jcrs.2006.03.021. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Uncorrected distance and near vision Uncorrected distance of 20/40 and near of J4 3 months postoperatively
Secondary Spherical error Spherical error on manifest refraction 3 months postoperatively
Secondary astigmatic error astigmatic error on manifest refraction 3 months postoperatively
Secondary Pupil size Pupil size in mesopic condition 3 months postoperatively
Secondary Total spherical and vertical coma aberrations Total spherical and vertical coma aberrations on aberrometry 3 months postoperatively
Secondary Reading speed and critical font size Measured on Salzburg's reading desk 3 months postoperatively
See also
  Status Clinical Trial Phase
Recruiting NCT01193504 - Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification Phase 4
Completed NCT00347243 - Wavefront Analisys and Contrast Sensitivity of Spherical and Aspherical Intraocular Lenses Phase 4
Completed NCT04208633 - Correlation Between Sulcus Anatomy and Other Parameters After Horizontal & Vertical Intraocular Lens (IOLs) Placements N/A
Recruiting NCT06041139 - Visual Outcomes and Patient Satisfaction With Bilateral PanOptix Verses Bilateral Synergy
Recruiting NCT04533191 - Binocular Custom Vision Utilizing The Light Adjustable Lens (LAL)
Completed NCT05735990 - Retrospective Clinical Investigation of the Safety and Performance of 640PM Trifocal IOL Implantation in Patients With Cataract and/or Ametropia (Hyperopia, Myopia) and/or Presbyopia
Recruiting NCT04175951 - Tecnis Eyhance Versus Rayner RayOne Study N/A
Not yet recruiting NCT06056154 - Safety and Efficacy of the Hydrophobic Intraocular Lens AsqelioTM Monofocal With Biaspheric Design
Not yet recruiting NCT05531110 - Comparison of Two Aspheric Intraocular Lenses for Micro-monovision N/A
Completed NCT01004549 - An Open-Label Evaluation of Degree of Accommodation in Pseudophakic Patients Bilaterally Implanted With Monofocal Intraocular Lenses N/A
Recruiting NCT03823092 - Polarization Perception in Health and Disease. Testing a New Sight Test
Completed NCT05226884 - Intermediate Vision in Patients With Clareon IOLs Compared to Eyhance IOLs
Completed NCT01310127 - Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Phase 4
Completed NCT05335408 - Evaluation of Visual Function After Bilateral Implantation of EDOF IOLs N/A
Completed NCT05611073 - Maximizing Visual Outcomes With Eyhance IOLs
Completed NCT04319497 - Subjective and Objective Refraction in Pseudophakic Patients N/A
Completed NCT05418153 - Synergy Lens Outcomes Evaluation
Recruiting NCT06065072 - Comparative Study of the Tomey OA-2000, Tomey CASIA2, and the LenStar LS900
Completed NCT02450799 - Corrected VA With Long-Term Follow-Up After AcrySof® Intraocular Lens (IOL) Implantation N/A
Completed NCT00428363 - Effect of Optic Edge Design in a Silicone Intraocular Lens on Posterior Capsule Opacification Phase 4